Retroperitoneal Lymph Node Dissection

PROCEDURE3 trials

Sponsors

University of Southern California, Queen Mary University of London, Western University, Canada

Conditions

LymphadenopathySeminomaStage I Testicular SeminomaStage II Testicular SeminomaTesticular Cancer

Phase 2

A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases

RecruitingNCT06932458

Western University, CanadaTesticular Cancer

Start: 2025-07-17End: 2030-06-01Target: 30Updated: 2025-07-20

Unknown Phase

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

Active, not recruitingNCT02537548

University of Southern CaliforniaLymphadenopathy, Stage II Testicular Seminoma, Stage I Testicular Seminoma

Start: 2015-08-28End: 2027-12-31Updated: 2026-06-09

THERApy De-escalation for TESTicular Cancer

RecruitingNCT06309745

Queen Mary University of LondonSeminoma

Start: 2024-06-24End: 2028-10-02Target: 30Updated: 2026-03-02

Related Papers

SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.

Journal of Clinical Oncology2021-02-2032 citations

Editorial introductions

Current Opinion in Urology2018-07-25